ABIVAX Société Anonyme
AAVXF
$6.91
$1.0217.32%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -70.11% | -58.56% |
| Total Other Revenue | 107.34% | 57.01% | 2.99% | -42.70% | -51.55% |
| Total Revenue | 107.34% | 57.01% | 2.99% | -42.70% | -51.55% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 107.34% | 57.01% | 2.99% | -77.55% | -86.00% |
| SG&A Expenses | 271.97% | 285.92% | 300.94% | 254.04% | 168.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -149.50% | -12.34% | 39.04% | -101.83% | 91.55% |
| Total Operating Expenses | 137.25% | 143.05% | 146.58% | 101.19% | 63.60% |
| Operating Income | -139.08% | -149.27% | -159.32% | -126.51% | -80.32% |
| Income Before Tax | -99.37% | -122.36% | -152.45% | -125.39% | -87.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -99.37% | -122.36% | -152.45% | -121.81% | -80.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -99.37% | -122.36% | -152.45% | -121.81% | -80.73% |
| EBIT | -139.08% | -149.27% | -159.32% | -126.51% | -80.32% |
| EBITDA | -139.04% | -149.21% | -159.24% | -126.44% | -80.27% |
| EPS Basic | -0.88% | -7.03% | -11.42% | -10.86% | -8.11% |
| Normalized Basic EPS | -6.51% | -25.14% | -47.56% | -47.83% | -44.78% |
| EPS Diluted | -0.88% | -7.03% | -11.42% | -10.86% | -8.11% |
| Normalized Diluted EPS | -6.51% | -25.14% | -47.56% | -47.83% | -44.78% |
| Average Basic Shares Outstanding | 97.36% | 108.64% | 125.57% | 100.09% | 71.06% |
| Average Diluted Shares Outstanding | 97.36% | 108.64% | 125.57% | 100.09% | 71.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
